Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
APP - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 78 | 76 |
|
Amyotrophic Lateral Sclerosis (ALS) / Dementia Panel Centogene AG - the Rare Disease Company Germany | 64 | 66 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Invitae Hereditary Cerebral Small Vessel Disease Panel Invitae United States | 24 | 10 |
|
Invitae United States | 72 | 33 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Alzheimer's Disease, Familial or Cerebral Amyloid Angiopathy via the APP Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Baylor Genetics United States | 842 | 637 |
|
Genologica Medica Spain | 25 | 10 |
|
Dementia panel. NGS panel of 21 genes. Genologica Medica Spain | 44 | 21 |
|
Genologica Medica Spain | 44 | 19 |
|
Alzheimer's panel. NGS panel of 10 genes. Genologica Medica Spain | 25 | 10 |
|
Cerebral amyloid angiopathy: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 3 | 3 |
|
Alzheimer Disease, APP Gene Genetic Analysis, Alzheimer Type 1 Duzen Laboratories Duzen BBAGUAS Turkey | 2 | 1 |
|
Alzheimer Disease, APP Gene Exon 16 & 17 Genetic Analysis, Alzheimer Type 1 Duzen Laboratories Duzen BBAGUAS Turkey | 2 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.